|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Net product sales | |||||
| Alliance and other revenues | |||||
| Total Revenues | |||||
| Cost of products sold | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Acquired IPRD | |||||
| Amortization of acquired intangible assets | |||||
| Other (income)/expense, net | |||||
| Total Expenses | |||||
| Earnings/(Loss) before income taxes | |||||
| Income tax provision | |||||
| Net earnings/(loss) | |||||
| Noncontrolling Interest | |||||
| Net earnings/(loss) attributable to BMS | |||||
| Earnings/(Loss) per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) |
Loading...
